Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2018

01-09-2018 | Original Article

Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study

Authors: Xiaojiong Jia, Congya Li, Ju Cao, Xianan Wu, Liping Zhang

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2018

Login to get access

Abstract

Although candidemia has been reported globally, little is known about the differences in candidemia episodes between ICU and surgical wards or the correlation between serum biomarkers and mortality from candidemia. A retrospective study of hospitalized patients with candidemia was conducted in southwest China. A total of 198 non-duplicate candidemia episodes were identified between January 2011 and December 2016. Candida albicans was the leading species causing candidemia (34.9%), and 78.8% of these isolates were susceptible to fluconazole. More than half of candidemic patients were hospitalized in surgical wards, but the incidence of these surgical patients was much lower than that of ICU patients. Compared with surgical patients, patients admitted to ICU were more frequently subjected to extensive invasive procedures, severe clinical presentations, and heavy exposure to antibiotics. In addition, the mortality in ICU was significantly higher than that in surgical wards. Multivariable analysis revealed that ascites, catheter-related candidemia, ICU admission, septic shock, and concomitant bacterial infection were independent factors associated with mortality. Moreover, we observed that high PCT and BDG levels as well as low PLT counts were also associated with mortality from candidemia. Better understanding of the specific predictors in different wards could facilitate the identification of high-risk candidates to receive early antifungal therapy, thus improving the outcomes of critically ill patients with candidemia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rajendran R, Sherry L, Deshpande A et al (2016) A prospective surveillance study of Candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front Microbiol 7:915CrossRefPubMedPubMedCentral Rajendran R, Sherry L, Deshpande A et al (2016) A prospective surveillance study of Candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front Microbiol 7:915CrossRefPubMedPubMedCentral
2.
go back to reference Magill SS, Edwards JR, Bamberg W et al (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198–1208CrossRefPubMedPubMedCentral Magill SS, Edwards JR, Bamberg W et al (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198–1208CrossRefPubMedPubMedCentral
3.
go back to reference Strollo S, Lionakis MS, Adjemian J et al (2016) Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012(1). Emerg Infect Dis 23(1):7–13CrossRefPubMed Strollo S, Lionakis MS, Adjemian J et al (2016) Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012(1). Emerg Infect Dis 23(1):7–13CrossRefPubMed
4.
go back to reference Peman J, Canton E, Quindos G et al (2012) Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 67(5):1181–1187CrossRefPubMed Peman J, Canton E, Quindos G et al (2012) Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 67(5):1181–1187CrossRefPubMed
5.
6.
go back to reference Clancy CJ, Nguyen MH (2013) Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 56(9):1284–1292CrossRefPubMed Clancy CJ, Nguyen MH (2013) Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 56(9):1284–1292CrossRefPubMed
7.
go back to reference Rios-Toro JJ, Marquez-Coello M, Garcia-Alvarez JM et al (2017) Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLoS One 12(4):e0175254CrossRefPubMedPubMedCentral Rios-Toro JJ, Marquez-Coello M, Garcia-Alvarez JM et al (2017) Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLoS One 12(4):e0175254CrossRefPubMedPubMedCentral
8.
go back to reference Arai T, Kumasaka K, Nagata K et al (2014) Prediction of blood culture results by measuring procalcitonin levels and other inflammatory biomarkers. Am J Emerg Med 32(4):330–333CrossRefPubMed Arai T, Kumasaka K, Nagata K et al (2014) Prediction of blood culture results by measuring procalcitonin levels and other inflammatory biomarkers. Am J Emerg Med 32(4):330–333CrossRefPubMed
9.
go back to reference Rodriguez L, Bustamante B, Huaroto L et al (2017) A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes. PloS One 12(4):e0175172CrossRefPubMedPubMedCentral Rodriguez L, Bustamante B, Huaroto L et al (2017) A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes. PloS One 12(4):e0175172CrossRefPubMedPubMedCentral
10.
go back to reference Teo JQ, Candra SR, Lee SJ et al (2017) Candidemia in a major regional tertiary referral hospital—epidemiology, practice patterns and outcomes. Antimicrob Resist Infect Control 6:27CrossRefPubMedPubMedCentral Teo JQ, Candra SR, Lee SJ et al (2017) Candidemia in a major regional tertiary referral hospital—epidemiology, practice patterns and outcomes. Antimicrob Resist Infect Control 6:27CrossRefPubMedPubMedCentral
11.
go back to reference Falagas ME, Roussos N, Vardakas KZ (2010) Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 14(11):e954–e966CrossRefPubMed Falagas ME, Roussos N, Vardakas KZ (2010) Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 14(11):e954–e966CrossRefPubMed
12.
go back to reference Tan TY, Hsu LY, Alejandria MM et al (2016) Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. Med Mycol 54(5):471–477CrossRefPubMed Tan TY, Hsu LY, Alejandria MM et al (2016) Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. Med Mycol 54(5):471–477CrossRefPubMed
13.
go back to reference Siri L, Legarraga P, Garcia P et al (2017) Clinical and epidemiological changes of candidemia among adult patients from 2000 to 2013. Rev Chil Infectol 34(1):19–26CrossRef Siri L, Legarraga P, Garcia P et al (2017) Clinical and epidemiological changes of candidemia among adult patients from 2000 to 2013. Rev Chil Infectol 34(1):19–26CrossRef
14.
go back to reference Pfaller MA, Diekema DJ, Gibbs DL et al (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48(4):1366–1377CrossRefPubMedPubMedCentral Pfaller MA, Diekema DJ, Gibbs DL et al (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48(4):1366–1377CrossRefPubMedPubMedCentral
15.
go back to reference Pfaller MA, Messer SA, Hollis RJ et al (2009) Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. J Clin Microbiol 47(10):3185–3190CrossRefPubMedPubMedCentral Pfaller MA, Messer SA, Hollis RJ et al (2009) Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. J Clin Microbiol 47(10):3185–3190CrossRefPubMedPubMedCentral
16.
go back to reference Chapman B, Slavin M, Marriott D et al (2017) Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother 72(4):1103–1108CrossRefPubMed Chapman B, Slavin M, Marriott D et al (2017) Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother 72(4):1103–1108CrossRefPubMed
17.
go back to reference Kurosaki M, Nakanishi H, Izumi N (2017) Management of ascites in cirrhotic patients. Nihon Shokakibyo Gakkai Zasshi 114(1):27–34PubMed Kurosaki M, Nakanishi H, Izumi N (2017) Management of ascites in cirrhotic patients. Nihon Shokakibyo Gakkai Zasshi 114(1):27–34PubMed
18.
go back to reference Charles PE, Dalle F, Aho S et al (2006) Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med 32(10):1577–1583CrossRefPubMed Charles PE, Dalle F, Aho S et al (2006) Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med 32(10):1577–1583CrossRefPubMed
19.
go back to reference Miglietta F, Faneschi ML, Lobreglio G et al (2015) Procalcitonin, C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis, SIRS and systemic candidiasis. Infez Med 23(3):230–237PubMed Miglietta F, Faneschi ML, Lobreglio G et al (2015) Procalcitonin, C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis, SIRS and systemic candidiasis. Infez Med 23(3):230–237PubMed
20.
go back to reference Arai T, Ohta S, Tsurukiri J et al (2016) Procalcitonin levels predict to identify bacterial strains in blood cultures of septic patients. Am J Emerg Med 34(11):2150–2153CrossRefPubMed Arai T, Ohta S, Tsurukiri J et al (2016) Procalcitonin levels predict to identify bacterial strains in blood cultures of septic patients. Am J Emerg Med 34(11):2150–2153CrossRefPubMed
Metadata
Title
Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study
Authors
Xiaojiong Jia
Congya Li
Ju Cao
Xianan Wu
Liping Zhang
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3304-9

Other articles of this Issue 9/2018

European Journal of Clinical Microbiology & Infectious Diseases 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.